{"id":"NCT01028378","sponsor":"Clinical Research Consultants, Inc.","briefTitle":"Safety and Efficacy Study of Topography-Guided LASIK to Treat Myopia and Hyperopia","officialTitle":"Topography-Guided LASIK Using the ALLEGRETTO WAVE Eye-Q 400 Hz Excimer Laser System For the Treatment of Manifest and Cornea Based Myopic and Hyperopic Optical Errors","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-10","primaryCompletion":"2012-04","completion":null,"firstPosted":"2009-12-09","resultsPosted":"2016-04-11","lastUpdate":"2016-04-11"},"enrollment":212,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Myopia","Hyperopia"],"interventions":[{"type":"DEVICE","name":"T-CAT topography-guided LASIK treatment with the Allegretto Wave Eye-Q 400 Hz Excimer Laser","otherNames":[]}],"arms":[{"label":"Topography-guided LASIK","type":"EXPERIMENTAL"}],"summary":"This purpose of this study is to evaluate the safety and effectiveness of a topography-based custom ablation treatment using the ALLEGRETTO WAVEÂ® Eye-Q 400 Hz laser system for treating myopia and hyperopia.","primaryOutcome":{"measure":"Percentage of Eyes With Manifest Refraction Spherical Equivalent (MRSE) +/- 0.50 D","timeFrame":"12 month","effectByArm":[{"arm":"Topography-guided LASIK","deltaMin":94.78,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":11,"exclusionCount":19},"locations":{"siteCount":10,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":195},"commonTop":["BSCVA loss of 2 or more lines","Retinal Detachments"]}}